Immunefi
Immunefi

Immunefi

Measured by AhrefsDR77Ahrefs DR: 77/100. Top 25%. Measured by Ahrefs. Median 44.Measured by StartupHub.aiAgent43Agent Readiness: 43/100. Above median. Measured by StartupHub.ai. Median 41.Measured by Google PageSpeedSpeed63Site Speed: 63/100. Above median. Measured by Google PageSpeed. Median 62.Measured by StartupHub.aiTrust92Data Trust: 92/100. Top 25%. Measured by StartupHub.ai. Median 61.

The leading bug bounty and security services platform for Web3 projects.

2020Active136Miami, United States

About

Immunefi is the premier bug bounty and security services platform dedicated to Web3. They empower blockchain projects to secure their code and smart contracts by connecting them with a global community of security researchers. Immunefi offers bug bounty programs, vulnerability disclosure programs, and other security services to protect the decentralized ecosystem.

Key facts

Website
immunefi.com
Headquarters
Miami, United States
Founded
2020
Employees
136
Total funding
$27M (Series A)
Business model
B2B

Funding rounds

Funding rounds raised by Immunefi
DateRoundAmountLead investors
27 Apr 2022Series A$22MLightspeed Venture Partners
21 Jul 2021Seed$5MFramework Ventures

Tech stack

Detected on immunefi.com, last scanned 5 Nov 2026.

Frontend
Next.js, Tailwind CSS
CDN
Cloudflare, Vercel
Email provider
Google Workspace

Test your Ahrefs DR

The backlink strength of a domain, on the Ahrefs 0 to 100 scale. About a minute.

Write the first review

Frequently asked

Is Immunefi trustworthy and reputable?

StartupHub's Data Trust & Reputation score for Immunefi is 92 out of 100, a trusted rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.

How much funding has Immunefi raised?

Immunefi has raised a total of $27M in funding. The most recent round on record is Series A.

How many employees does Immunefi have?

Immunefi has approximately 136 people on record.

SEC filings, insider activity, nonprofit links and pay benchmarks for Immunefi:

Company details: from public sources. Funding: no announced round on file. Ownership: not yet claimed by the company. Scores: measured by named tools; each links to its method. Our rules